Cited by 5,850Lipoproteins and Cardiovascular HealthInflammatory Biomarkers in Disease PrognosisAdipokines, Inflammation, and Metabolic Diseases

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women

Open access

Ridker, Paul M., Hennekens, Charles H., Buring, Julie E., Rifai, Nader·2000·New England Journal of Medicine

DOI 10.1056/nejm200003233421202

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Since inflammation is believed to have a role in the pathogenesis of cardiovascular events, measurement of markers of inflammation has been proposed as a method to improve the prediction of the risk of these events. METHODS: We conducted a prospective, nested case-control study among 28,263 apparently healthy postmenopausal women over a mean follow-up period of three years to assess the risk of cardiovascular events associated with base-line levels of markers of inflammation. The markers included high-sensitivity C-reactive protein (hs-CRP), serum amyloid A, interleukin-6, and soluble intercellular adhesion molecule type 1 (sICAM-1). We also studied homocysteine and a variety of lipid and lipoprotein measurements. Cardiovascular events were defined as death from coronary heart disease, nonfatal myocardial infarction or stroke, or the need for coronary-revascularization procedures. RESULTS: Of the 12 markers measured, hs-CRP was the strongest univariate predictor of the risk of cardiovascular events; the relative risk of events for women in the highest as compared with the lowest quartile for this marker was 4.4 (95 percent confidence interval, 2.2 to 8.9). Other markers significantly associated with the risk of cardiovascular events were serum amyloid A (relative risk for the highest as compared with the lowest quartile, 3.0), sICAM-1 (2.6), interleukin-6 (2.2), homocysteine (2.0), total cholesterol (2.4), LDL cholesterol (2.4), apolipoprotein B-100 (3.4), HDL cholesterol (0.3), and the ratio of total cholesterol to HDL cholesterol (3.4). Prediction models that incorporated markers of inflammation in addition to lipids were significantly better at predicting risk than models based on lipid levels alone (P<0.001). The levels of hs-CRP and serum amyloid A were significant predictors of risk even in the subgroup of women with LDL cholesterol levels below 130 mg per deciliter (3.4 mmol per liter), the target for primary prevention established by the National Cholesterol Education Program. In multivariate analyses, the only plasma markers that independently predicted risk were hs-CRP (relative risk for the highest as compared with the lowest quartile, 1.5; 95 percent confidence interval, 1.1 to 2.1) and the ratio of total cholesterol to HDL cholesterol (relative risk, 1.4; 95 percent confidence interval, 1.1 to 1.9). CONCLUSIONS: The addition of the measurement of C-reactive protein to screening based on lipid levels may provide an improved method of identifying persons at risk for cardiovascular events.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejm200003233421202

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Self-citation
Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels: Results of AFCAPS/TexCAPS
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236
PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA
Hepherd, J. A. S., Obbe, S. T. M. C., Ord, I. A. F., Sles, C. H. G. I., Orimer, A. R. O. L., Acfarlane, P. E. W. M., Illop, J. A. H. M. C. K., Ackard, C. H. J. P., & Roup, S. T. G. (1995) · Cited by 3,453
The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina
Liuzzo, G., Biasucci, L. M., Gallimore, J. R., Grillo, R. L., Rebuzzi, A. G., Pepys, M. B., & Maseri, A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408183310701 · Cited by 2,354
C-Reactive Protein, a Sensitive Marker of Inflammation, Predicts Future Risk of Coronary Heart Disease in Initially Healthy Middle-Aged Men
Köenig, W., Sund, M., Fröhlich, M., Fischer, H.-G., Löwel, H., Döring, A., Hutchinson, W. L., & Pepys, M. B. (1999) · Circulation · doi:10.1161/01.cir.99.2.237 · Cited by 1,952
Prospective Study of C-Reactive Protein and the Risk of Future Cardiovascular Events Among Apparently Healthy Women
Ridker, P. M., Buring, J. E., Shih, J., Matias, M., & Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.98.8.731 · Cited by 1,642
Self-citation
Production of C-reactive protein and risk of coronary events in stable and unstable angina
Haverkate, E., Thompson, S. G., Pyke, S., Gallimore, J. R., & Mark B Pepys Group (1997) · The Lancet · doi:10.1016/s0140-6736(96)07591-5 · Cited by 1,511

Show all 30 references

Research works printed but not linked: 1

Buring JE, 1992, J Myocard Ischemia, 4, 27

Sorted by citations

Items 901–1,000 of 1,069

Relation of depressive symptoms to C-reactive protein and pathogen burden (cytomegalovirus, herpes simplex virus, Epstein-Barr virus) in patients with earlier acute coronary syndromes
Miller, G. E., Freedland, K. E., Duntley, S. P., & Carney, R. M. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.09.026 · Cited by 125
Elevated Soluble Cellular Adhesion Molecules in Subjects With Low HDL-Cholesterol
Calabresi, L., Gomaraschi, M., Villa, B., Omoboni, L., Dmitrieff, C., & Franceschini, G. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0402.105901 · Cited by 125
Comparative proteome analyses of human plasma following in vivo lipopolysaccharide administration using multidimensional separations coupled with tandem mass spectrometry
Qian, W., Jacobs, J., Camp, D., Monroe, M. E., Moore, R., Gritsenko, M. A., Calvano, S. E., Lowry, S. F., Xiao, W., Moldawer, L. L., et al. (2005) · PROTEOMICS · doi:10.1002/pmic.200400942 · Cited by 125
Serum carotenoids and vitamins in relation to markers of endothelial
Broekmans, W. M. R., Klöpping-Ketelaars, I. A. A., Bots, M. L., Kluft, C., Princen, H. M. G., Hendriks, F. J. H., Tijburg, L. B. M., van Poppel, G., & Kardinaal, A. F. M. (2004) · European Journal of Epidemiology · doi:10.1007/s10654-004-5760-z · Cited by 125
Garlic-Derived Organic Polysulfides and Myocardial Protection
Bradley, J., Organ, C. L., & Lefer, D. J. (2016) · Journal of Nutrition · doi:10.3945/jn.114.208066 · Cited by 124
Genome-wide association with select biomarker traits in the Framingham Heart Study
Benjamin, E. J., Dupuis, J., Larson, M. G., Lunetta, K. L., Booth, S. L., Govindaraju, D. R., Kathiresan, S., Keaney, J. F., Keyes, M. J., Lin, J., et al. (2007) · BMC Medical Genetics · doi:10.1186/1471-2350-8-s1-s11 · Cited by 124
High-Sensitivity C-Reactive Protein and Cardiovascular Disease Across Countries and Ethnicities
Fonseca, F. A. H., & Izar, M. C. D. O. (2016) · Clinics · doi:10.6061/clinics/2016(04)11 · Cited by 123
Hypoxemia and obesity modulate plasma C-reactive protein and interleukin-6 levels in sleep-disordered breathing
Tauman, R., O'Brien, L. M., & Gozal, D. (2006) · Sleep And Breathing · doi:10.1007/s11325-006-0085-7 · Cited by 123
Poor oral health is associated with coronary heart disease and elevated systemic inflammatory and haemostatic factors
Montebugnoli, L., Servidio, D., MIATON, R. A., Prati, C., Tricoci, P., & Melloni, C. (2003) · Journal Of Clinical Periodontology · doi:10.1111/j.0303-6979.2004.00432.x · Cited by 123
C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patients
Zimmermann, E., Anty, R., Tordjman, J., Verrijken, A., Gual, P., Tran, A., Iannelli, A., Gugenheim, J., Bédossa, P., Francque, S., et al. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.12.017 · Cited by 123
The Glycemic Index: Physiological Significance
Esfahani, A., Wong, J. M., Mirrahimi, A., Srichaikul, K., Jenkins, D. J. A., & Kendall, C. W. C. (2009) · Journal of the American College of Nutrition · doi:10.1080/07315724.2009.10718109 · Cited by 123
Biomarkers and Cardiovascular Risk Assessment for Primary Prevention: An Update
Gilstrap, L. G., & Wang, T. J. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2011.165712 · Cited by 122
Influence of an algal triacylglycerol containing docosahexaenoic acid (22:6n-3) and docosapentaenoic acid (22:5n-6) on cardiovascular risk factors in healthy men and women
Sanders, T. A. B., Gleason, K. L. T., Griffin, B. A., & Miller, G. J. (2006) · British Journal Of Nutrition · doi:10.1079/bjn20051658 · Cited by 122
Predictors of cardiovascular damage in patients with systemic lupus erythematosus: data from LUMINA (LXVIII), a multiethnic US cohort
Pons‐Estel, G., Gonzalez, L. A., Zhang, J., Burgos, P. I., Reveille, J. D., Vilá, L. M., & Alarcón, G. S. (2009) · Rheumatology · doi:10.1093/rheumatology/kep102 · Cited by 122
Sudden Cardiac Death, Genes, and Arrhythmogenesis
Spooner, P. M., Albert, C. M., Benjamin, E. J., Boineau, R., Elston, R. C., George, A. L., Jouven, X., Kuller, L. H., MacCluer, J. W., Marbán, E., et al. (2001) · Circulation · doi:10.1161/01.cir.103.19.2361 · Cited by 122
Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program
Weir, M. R., SPERLING, R. S., Reicin, A. S., & Gertz, B. J. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00398-3 · Cited by 122
Selected dietary flavonoids are associated with markers of inflammation and endothelial dysfunction in U.S. women
Landberg, R., Sun, Q., Rimm, E. B., Cassidy, A., Scalbert, A., Mantzoros, C. S., Hu, F. B., & van Dam, R. M. (2011) · The Journal of Nutrition · doi:10.3945/jn.110.133843 · Cited by 121
Global burden of atherosclerotic cardiovascular disease in people with hepatitis C virus infection: a systematic review, meta-analysis, and modelling study
Lee, K. K., Stelzle, D., Bing, R., Anwar, M., Strachan, F. E., Bashir, S., Newby, D. E., Shah, J., Chung, M. H., Bloomfield, G. S., et al. (2019) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(19)30227-4 · Cited by 121
Adverse outcome in aortic sclerosis is associated with coronary artery disease and inflammation
Chandra, H. R., Goldstein, J. A., Choudhary, N., O'Neill, C. S., George, P. B., Gangasani, S. R., Cronin, L., Marcovitz, P. A., Hauser, A. M., & O’Neill, W. W. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.08.036 · Cited by 121
Angiotensin-Converting Enzyme Inhibitor Use Is Associated With Reduced Plasma Concentration of C-Reactive Protein in Patients With First-Ever Ischemic Stroke
Napoli, M. D., & Papa, F. (2003) · Stroke · doi:10.1161/01.str.0000099124.84425.bb · Cited by 121
Low-Level Endotoxin Induces Potent Inflammatory Activation of Human Blood Vessels
Rice, J. B., Stoll, L. L., Li, W.-G., Denning, G. M., Weydert, J. A., Charipar, E. M., Richenbacher, W. E., Miller, F. J., & Weintraub, N. L. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000081741.38087.f9 · Cited by 121
Serum Levels of C-reactive Protein Are Associated with Obesity, Weight Gain, and Hormone Replacement Therapy in Healthy Postmenopausal Women
Barinas‐Mitchell, E. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.11.1094 · Cited by 121
Particle-Induced Pulmonary Acute Phase Response Correlates with Neutrophil Influx Linking Inhaled Particles and Cardiovascular Risk
Saber, A. T., Lamson, J. S., Jacobsen, N. R., Ravn‐Haren, G., Hougaard, K. S., Nyendi, A. N., Wahlberg, P., Madsen, A. M., Jackson, P., Wallin, H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069020 · Cited by 120
Chronic obstructive pulmonary disease and sudden cardiac death: the Rotterdam study
Lahousse, L., Niemeijer, M. N., van den Berg, M. E., Rijnbeek, P. R., Joos, G., Albert Hofman, D., Franco, O. H., Deckers, J. W., Eijgelsheim, M., Stricker, B. H. C., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv121 · Cited by 120
Effects of ACE-Inhibitors and Angiotensin Receptor Blockers on Inflammation
Raimondo, D. D., Tuttolomondo, A., Buttà, C., Miceli, S., Licata, G., & Pinto, A. V. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802481282 · Cited by 120
Modulation of inflammation by chondroitin sulfate
Vallières, M., & du Souich, P. (2010) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2010.02.017 · Cited by 120
Inflammation, Atherosclerosis, and Stroke
Elkind, M. S. V. (2006) · The Neurologist · doi:10.1097/01.nrl.0000215789.70804.b0 · Cited by 120
Joint Effect of Hostility and Severity of Depressive Symptoms on Plasma Interleukin-6 Concentration
Suarez, E. C. (2003) · Psychosomatic Medicine · doi:10.1097/01.psy.0000062530.94551.ea · Cited by 120
Intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM)-1 at the early stages of atherosclerosis in a rat model.
Fotis, L., Agrogiannis, G., Vlachos, I. S., Pantopoulou, A., Margoni, A., Kostaki, M., Verikokos, C., Tzivras, D. M., Mikhailidis, D. P., & Perrea, D. N. (2012) · PubMed · Cited by 120
Effect of Rosiglitazone on Endothelial Function and Inflammatory Markers in Patients With the Metabolic Syndrome
Esposito, K., Ciotola, M., Carleo, D., Schisano, B., Saccomanno, F., Sasso, F. C., Cozzolino, D., Assaloni, R., Merante, D., Ceriello, A., et al. (2006) · Diabetes Care · doi:10.2337/dc05-2174 · Cited by 120
Increased Serum Amyloid A Concentrations in Morbid Obesity Decrease after Gastric Bypass
Gómez-Ambrosi, J., Salvador, J., Rotellar, F., Silva, C., Catalán, V., Rodríguez, A., Jesús Gil, M., & Frühbeck, G. (2006) · Obesity Surgery · doi:10.1381/096089206776116525 · Cited by 119
Cardiovascular disease and the role of oral bacteria
Leishman, S. J., Lien, H., & Ford, P. J. (2010) · Journal of Oral Microbiology · doi:10.3402/jom.v2i0.5781 · Cited by 119
Transcriptional Complex Formation of c-Fos, STAT3, and Hepatocyte NF-1α Is Essential for Cytokine-Driven C-Reactive Protein Gene Expression
Nishikawa, T., Hagihara, K., Serada, S., Isobe, T., Matsumura, A., Song, J., Tanaka, T., Kawase, I., Naka, T., & Yoshizaki, K. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.3492 · Cited by 119
Homocysteine and cardiovascular disease: biological mechanisms, observational epidemiology, and the need for randomized trials
Splaver, A., Lamas, G. A., & Hennekens, C. H. (2004) · American Heart Journal · doi:10.1016/j.ahj.2004.02.004 · Cited by 119
Self-citation
Cardiovascular co-morbidity in chronic kidney disease: Current knowledge and future research needs
Alani, H. (2014) · World Journal of Nephrology · doi:10.5527/wjn.v3.i4.156 · Cited by 119
The association of c-reactive protein, serum amyloid a and fibrinogen with prevalent coronary heart disease — baseline findings of the PAIS project
Jousilahti, P. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00681-x · Cited by 119
High-sensitive C-reactive protein, tumor necrosis factor α, and cardiovascular risk factors before and after weight loss in obese children
Reinehr, T., Stoffel‐Wagner, B., Roth, C. L., & Andler, W. (2005) · Metabolism · doi:10.1016/j.metabol.2005.03.022 · Cited by 119
Impact of pathogen burden in patients with coronary artery disease in relation to systemic inflammation and variation in genes encoding cytokines
Georges, J., Rupprecht, H. J., Blankenberg, S., Poirier, O., Bickel, C., Hafner, G., Nicaud, V., Meyer, J., Cambien, F., & Tiret, L. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00717-3 · Cited by 119
Cardiovascular risk associated with the metabolic syndrome
Lindsay, R. S., & Howard, B. V. (2004) · Current Diabetes Reports · doi:10.1007/s11892-004-0013-9 · Cited by 119
Effect of Transdermal Estradiol and Oral Conjugated Estrogen on C-Reactive Protein in Retinoid-Placebo Trial in Healthy Women
DeCensi, A., Omodei, U., Robertson, C., Bonanni, B., Guerrieri‐Gonzaga, A., Ramazzotto, F., Johansson, H. A., Mora, S., Sandri, M. T., Cazzaniga, M., et al. (2002) · Circulation · doi:10.1161/01.cir.0000028463.74880.ea · Cited by 119
Effect of Periodontal Treatment on Serum C‐Reactive Protein Levels: A Systematic Review and Meta‐Analysis
Ioannidou, E., Malekzadeh, T., & Dongari‐Bagtzoglou, A. (2006) · Journal of Periodontology · doi:10.1902/jop.2006.050443 · Cited by 118
Circulating Adipokines and Inflammatory Markers and Postmenopausal Breast Cancer Risk
Gunter, M. J., Wang, T., Cushman, M., Xue, X., Wassertheil-Smoller, S. W., Strickler, H. D., Rohan, T. E., Manson, J. E., McTiernan, A., Kaplan, R. C., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv169 · Cited by 118
Metabolic Activity of the Spleen and Bone Marrow in Patients With Acute Myocardial Infarction Evaluated by 18 F-Fluorodeoxyglucose Positron Emission Tomograpic Imaging
Kim, E. J., Kim, S., Kang, D. O., & Seo, H. S. (2014) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.113.001093 · Cited by 118
Efficacy and safety of lipid lowering by alirocumab in chronic kidney disease
Toth, P. P., Dwyer, J. P., Cannon, C. P., Colhoun, H. M., Rader, D. J., Upadhyay, A., Louie, M. J., Koren, A., Letierce, A., Mandel, J., et al. (2018) · Kidney International · doi:10.1016/j.kint.2017.12.011 · Cited by 118
Increases in circulating levels of ketone bodies and cardiovascular protection with SGLT2 inhibitors: Is low‐grade inflammation the neglected component?
Prattichizzo, F., Nigris, V. D., Micheloni, S., Sala, L. L., & Ceriello, A. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13488 · Cited by 118
Subchronic exposure to concentrated ambient PM2.5 perturbs gut and lung microbiota as well as metabolic profiles in mice
Ran, Z., An, Y., Zhou, J., Yang, H. J., Zhang, Y., Yang, J., Wang, L., Li, X., Lu, D., Zhong, J. S., et al. (2020) · Environmental Pollution · doi:10.1016/j.envpol.2020.115987 · Cited by 118
Association between serum amyloid A and obesity: a meta-analysis and systematic review
Zhao, Y., He, X., Shi, X., Huang, C. M., Liu, J., Zhou, S., & Heng, C. (2010) · Inflammation Research · doi:10.1007/s00011-010-0163-y · Cited by 118
Increased levels of the inflammatory biomarker C‐reactive protein at baseline are associated with childhood sickle cell vasocclusive crises
Krishnan, S., Setty, Y. B. N., Betal, S. G., Vaidyula, V. R., Rao, K., Dampier, C., & Stuart, M. J. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.08013.x · Cited by 118
New Drugs for the Treatment of Diabetes Mellitus
McGuire, D. K., & Inzucchi, S. E. (2008) · Circulation · doi:10.1161/circulationaha.107.704080 · Cited by 118
Interrelationships Between Inflammation, C‐Reactive Protein, and Insulin Resistance
Ndumele, C. E., Pradhan, A. D., & Ridker, P. M. (2006) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4564.2006.05538.x · Cited by 118
Self-citation
Effect of Intensive Lifestyle Changes on Endothelial Function and on Inflammatory Markers of Atherosclerosis
Dod, H. S., Bhardwaj, R., Sajja, V., Weidner, G., Hobbs, G. R., Konat, G. W., Manivannan, S., Gharib, W., Warden, B. E., Nanda, N. C., et al. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.09.038 · Cited by 118
Erythrocyte Sedimentation Rate, an Independent Predictor of Coronary Heart Disease in Men and Women: The Reykjavik Study
Andresdottir, M. B. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg222 · Cited by 118
Pasta Naturally Enriched with Isoflavone Aglycons from Soy Germ Reduces Serum Lipids and Improves Markers of Cardiovascular Risk
Clerici, C., Setchell, K. D. R., Battezzati, P. M., Pirro, M., Giuliano, V., Asciutti, S., Castellani, D., Nardi, E., Sabatino, G., Orlandi, S., et al. (2007) · Journal of Nutrition · doi:10.1093/jn/137.10.2270 · Cited by 118
Effects of Initiating Insulin and Metformin on Glycemic Control and Inflammatory Biomarkers Among Patients With Type 2 Diabetes: The LANCET Randomized Trial
Pradhan, A. D., Everett, B. M., Cook, N. R., Rifai, N., & Ridker, P. M. (2009) · JAMA · doi:10.1001/jama.2009.1347 · Cited by 117
Self-citation
Effect of induced hypoglycemia on inflammation and oxidative stress in type 2 diabetes and control subjects
Kahal, H., Halama, A., Aburima, A. A., Bhagwat, A. M., Butler, A. E., Graumann, J., Suhre, K., Sathyapalan, T., & Atkin, S. L. (2020) · Scientific Reports · doi:10.1038/s41598-020-61531-z · Cited by 117
Should we consider gestational diabetes a vascular risk factor?
Bo, S., Valpreda, S., Menato, G., Bardelli, C., Botto, C., Gambino, R., Rabbia, C., Durazzo, M., Cassader, M., Massobrio, M., et al. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.09.017 · Cited by 117
Low plasma vitamin B-6 concentrations and modulation of coronary artery disease risk
Friso, S., Girelli, D., Martinelli, N., Olivieri, O., Lotto, V., Bozzini, C., Pizzolo, F., Faccini, G., Beltrame, F., & Corrocher, R. (2004) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.6.992 · Cited by 117
Intra-Arterial Tumor Necrosis Factor-α Impairs Endothelium-Dependent Vasodilatation and Stimulates Local Tissue Plasminogen Activator Release in Humans
Chia, S., Qadan, M., Newton, R., Ludlam, C. A., Fox, K. A. A., & Newby, D. E. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000065195.22904.fa · Cited by 117
Cardiovascular disease in chronic renal failure: the challenge continues
Locatelli, F., Marcelli, D., Conte, F., DʼAmico, M., Vecchio, L. D., Limido, A., Malberti, F., & Spotti, D. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.suppl_5.69 · Cited by 117
Association between Renal Insufficiency and Inducible Ischemia in Patients with Coronary Artery Disease
Ix, J. H., Shlipak, M. G., Liu, H. H., Schiller, N. B., & Whooley, M. A. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000095642.25603.7a · Cited by 117
Reduced expression of endothelial cell markers after 1 year treatment with simvastatin and atorvastatin in patients with coronary heart disease
Seljeflot, I., Tonstad, S., Hjermann, I., & Arnesen, H. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00696-7 · Cited by 117
Vitamin B status in patients with type 2 diabetes mellitus with and without incipient nephropathy
Nix, W. A., Zirwes, R., Bangert, V., Kaiser, R., Schilling, M., Gottwald‐Hostalek, U., & Obeid, R. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.09.058 · Cited by 116
Effects of oestrogen deprivation on interleukin-6 production by peripheral blood mononuclear cells of postmenopausal women
Rachoń, D., Myśliwska, J. M., Suchecka-Rachoń, K., Więckiewicz, J., & Myśliwski, A. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1720387 · Cited by 116
C-Reactive Protein Isoforms Differ in Their Effects on Thrombus Growth
Molins, B., Peña, E., Vilahur, G., Mendieta, C., SLEVIN, M. A., & Badimón, L. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.174359 · Cited by 116
Why is HDL functionally deficient in type 2 diabetes?
Kontush, A., & Chapman, M. J. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0010-5 · Cited by 116
Atherosclerosis, Dyslipidemia, and Inflammation: The Significant Role of Polyunsaturated Fatty Acids
Dessì, M., Noce, A., Bertucci, P., di Villahermosa, S. M., Zenobi, R., Castagnola, V., Addessi, E., & Daniele, N. D. (2013) · ISRN Inflammation · doi:10.1155/2013/191823 · Cited by 115
The effects of garlic extract upon endothelial function, vascular inflammation, oxidative stress and insulin resistance in adults with type 2 diabetes at high cardiovascular risk. A pilot double blind randomized placebo controlled trial
Atkin, M., Laight, D. W., & Cummings, M. H. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.01.003 · Cited by 115
Coronary Artery Disease in Women: A 2013 Update
Sharma, K., & Gulati, M. (2013) · Global Heart · doi:10.1016/j.gheart.2013.02.001 · Cited by 115
Interleukin 6 in diabetes, chronic kidney disease, and cardiovascular disease: mechanisms and therapeutic perspectives
Kreiner, F. F., Kraaijenhof, J. M., von Herrath, M., Hovingh, G. K., & von Scholten, B. J. (2022) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2022.2045952 · Cited by 115
Mechanisms of obesity and related pathologies: Androgen deficiency and endothelial dysfunction may be the link between obesity and erectile dysfunction
Traish, A. M., Feeley, R. J., & Guay, A. T. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07305.x · Cited by 115
Plasma cystatin-C and development of coronary heart disease: The PRIME Study
Luc, G., Bard, J., Lesueur, C., Arveiler, D., Evans, A., Amouyel, P., Ferrières, J., Juhan-Vague, I., Fruchart, J., & Ducimetière, P. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.06.017 · Cited by 115
Abnormal vitamin B6 status is associated with severity of symptoms in patients with rheumatoid arthritis
Chiang, E. I., Bagley, P. J., Selhub, J., Nadeau, M., & Roubenoff, R. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01528-0 · Cited by 115
Effect of Intensive Glycemic Control on Levels of Markers of Inflammation in Type 1 Diabetes Mellitus in the Diabetes Control and Complications Trial
Schaumberg, D. A., Glynn, R. J., Jenkins, A. J., Lyons, T. J., Rifai, N., Manson, J. E., Ridker, P. M., & Nathan, D. M. (2005) · Circulation · doi:10.1161/01.cir.0000165064.31505.3b · Cited by 115
Self-citation
Serum high sensitivity C-reactive protein and cognitive function in elderly women
Komulainen, P., Lakka, T. A., Kivipelto, M., Hassinen, M., Penttila, I. M., Helkala, E.-L., Gylling, H. K., Nissinen, A. M., & Rauramaa, R. (2007) · Age and Ageing · doi:10.1093/ageing/afm051 · Cited by 115
Antiepileptic Drugs and Markers of Vascular Risk
LoPinto‐Khoury, C., & Mintzer, S. (2010) · Current Treatment Options in Neurology · doi:10.1007/s11940-010-0080-y · Cited by 115
n-3 Polyunsaturated fatty acids, inflammation and obesity-related disease
Browning, L. M. (2003) · Proceedings of The Nutrition Society · doi:10.1079/pns2003252 · Cited by 115
Cardiovascular Risk Factors in Acromegaly before and after Normalization of Serum IGF-I Levels with the GH Antagonist Pegvisomant
Sesmilo, G., Fairfield, W. P., Katznelson, L. J., Pulaski, K., Freda, P. U., Bonert, V. S., Dimaraki, E. V., Stavrou, S., Vance, M. L., Hayden, D., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.4.8364 · Cited by 115
Serum Amyloid A and Lipoprotein Retention in Murine Models of Atherosclerosis
O’Brien, K. D., McDonald, T. O., Kunjathoor, V. V., Eng, K., Knopp, E. A., Lewis, K., Lopez, R., Kirk, E. A., Chait, A., Wight, T. N., et al. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000158383.65277.2b · Cited by 115
Is osteoarthritis a metabolic disorder?
Kluzek, S., Newton, J. L., & Arden, N. (2015) · British Medical Bulletin · doi:10.1093/bmb/ldv028 · Cited by 115
Serum markers of periodontal disease status and inflammation in hemodialysis patients
Rahmati, M. A., Craig, R. G., Homel, P., Kaysen, G. A., & Levin, N. W. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.36330 · Cited by 115
Inflammatory markers and coronary heart disease
Rifai, N., & Ridker, P. M. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200208000-00005 · Cited by 115
Self-citation
Intimal redox stress: Accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus. Atheroscleropathy
Hayden, M. R., & Tyagi, S. C. (2002) · Cardiovascular Diabetology · doi:10.1186/1475-2840-1-3 · Cited by 115
Biodemography: New approaches to understanding trends and differences in population health and mortality
Crimmins, E. M., Kim, J. K., & Vasunilashorn, S. M. (2010) · Demography · doi:10.1353/dem.2010.0005 · Cited by 114
Obesity and C‐reactive Protein Levels Among White, Black, and Hispanic US Adults
Wee, C. C., Mukamal, K. J., Huang, A., Davis, R. B., McCarthy, E. P., & Mittleman, M. A. (2008) · Obesity · doi:10.1038/oby.2008.7 · Cited by 114
Biomarkers of Vascular Inflammation for Cardiovascular Risk Prognostication
Antonopoulos, A. S., Angelopoulos, A., Papanikolaou, P., Simantiris, S., Oikonomou, E. K., Vamvakaris, K., Koumpoura, A., Farmaki, M., Trivella, M., Vlachopoulos, C. V., et al. (2021) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2021.09.014 · Cited by 114
Relationships of Plasma Interleukin-18 Concentrations to Hyperhomocysteinemia and Carotid Intimal-Media Wall Thickness in Patients With Type 2 Diabetes
Aso, Y., Okumura, K.-I., Takebayashi, K., Wakabayashi, S., & Inukai, T. (2003) · Diabetes Care · doi:10.2337/diacare.26.9.2622 · Cited by 114
Cells of the synovium in rheumatoid arthritis. Dendritic cells
Lutzky, V. P., Hannawi, S., & Thomas, R. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2200 · Cited by 114
Impact of dairy products on biomarkers of inflammation: a systematic review of randomized controlled nutritional intervention studies in overweight and obese adults
Labonté, M., Couture, P., Richard, C., Desroches, S., & Lamarche, B. (2013) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.052217 · Cited by 114
Vitamin B6: a challenging link between nutrition and inflammation in CVD
Lotto, V., Choi, S., & Friso, S. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511000407 · Cited by 114
Interleukin-6 serum levels and genotypes influence the risk for myocardial infarction
Bennet, A. (2003) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.08.029 · Cited by 113
A Plant Stanol Yogurt Drink Alone or Combined with a Low-Dose Statin Lowers Serum Triacylglycerol and Non-HDL Cholesterol in Metabolic Syndrome Patients
Plat, J., Brufau, G., Dallinga‐Thie, G. M., Dasselaar, M., & Mensink, R. P. (2009) · Journal of Nutrition · doi:10.3945/jn.108.103481 · Cited by 113
Plasma proprotein convertase subtilisin/kexin type 9 levels and the risk of first cardiovascular events
Ridker, P. M., Rifai, N., Bradwin, G., & Rose, L. M. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv568 · Cited by 113
Self-citation
Adiponectin in peritoneal dialysis patients: a comparison with hemodialysis patients and subjects with normal renal function
Huang, J., Yen, C., Chiang, H.-W., Hung, K., Tsai, T., & Wu, K. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.02.017 · Cited by 113
Adipose tissue changes in obesity and the impact on metabolic function
Sam, S., & Mazzone, T. (2014) · Translational research · doi:10.1016/j.trsl.2014.05.008 · Cited by 113
Critical Limb Ischemia: Epidemiology
Davies, M. G. (2012) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-8-4-10 · Cited by 113
Statins and inflammation: an update
Quist‐Paulsen, P. (2010) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3283398e53 · Cited by 113
Carotid plaque formation and serum biomarkers
Hermus, L., Lefrandt, J. D., Tio, R. A., Breek, J. C., & Zeebregts, C. J. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.05.013 · Cited by 113
Serum antibodies to periodontal pathogens and markers of systemic inflammation
Dye, B. A., Choudhary, K., Shea, S., & Papapanou, P. N. (2005) · Journal Of Clinical Periodontology · doi:10.1111/j.1600-051x.2005.00856.x · Cited by 113
C-reactive protein, arterial endothelial activation, and development of transplant coronary artery disease: a prospective study
Labarrere, C. A., Lee, J. B., Nelson, D. R., Al‐Hassani, M., Miller, S. J., & Pitts, D. E. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11473-5 · Cited by 113
Indices of low-grade inflammation in polycystic ovary syndrome
DIAMANTI‐KANDARAKIS, E., PATERAKIS, T., & KANDARAKIS, H. A. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1365.015 · Cited by 112

Authors: Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N.
Affiliations: Brigham and Women's Hospital (US)
Boston Children's Hospital (US)
ORCID: Ridker, Paul M.
Hennekens, Charles H.
Buring, Julie E.
Rifai, Nader
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2000-03-23
Volume: 342
Issue: 12
Pages: 836-843
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm200003233421202
OpenAlex: W2058610272
Cited by: 5,850
References: 30
Citations by year: 2026: 97 · 2025: 120 · 2024: 113 · 2023: 125 · 2022: 148 · 2021: 143 · 2020: 165 · 2019: 140 · 2018: 167 · 2017: 131 · 2016: 169 · 2015: 199 · 2014: 223 · 2013: 234 · 2012: 258
FWCI: 286.27
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
University Libraries (University of Maryland) (submittedVersion)
Digital Repository at the University of Maryland (University of Maryland College Park)
Funders: National Institutes of Health (5r01hl043851-10)
National Heart, Lung, and Blood Institute (R01HL058755, HL43851, HL-58755)
National Cancer Institute (CA-47988, R01CA047988)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Keywords: C-reactive protein, inflammatory markers, cardiovascular risk prediction, postmenopausal women, serum amyloid A, interleukin-6, sICAM-1, homocysteine, apolipoprotein B-100, LDL cholesterol, coronary artery disease, myocardial infarction, stroke, coronary revascularization, risk prediction model
MeSH terms: Serum Amyloid A Protein, Analysis of Variance, Apolipoproteins, C-Reactive Protein, Cardiovascular Diseases, Female, Homocysteine, Humans, Lipids, Middle Aged, Prospective Studies, Protein Precursors, Risk, Biomarkers, Interleukin-6, Case-Control Studies, Intercellular Adhesion Molecule-1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks